The global vitamin B3 market size is calculated at USD 394.83 million in 2025 and is forecasted to reach around USD 481.52 million by 2034, accelerating at a CAGR of 2.23% from 2025 to 2034. The Asia Pacific market size surpassed USD 146.76 million in 2024 and is expanding at a CAGR of 2.36% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Vitamin B3 Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Vitamin B3 Market Revenue and Volume, by Source
8.1.1 Natural
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Synthetic
8.1.2.1. Market Revenue and Volume Forecast
9.1. Vitamin B3 Market Revenue and Volume, by Form
9.1.1. Dry
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Liquid
9.1.2.1. Market Revenue and Volume Forecast
10.1. Vitamin B3 Market Revenue and Volume, by Application
10.1.1. Animal Feed
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Food and Beverage
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Pharmaceutical
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Cosmetics
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Source
11.1.2. Market Revenue and Volume Forecast, by Form
11.1.3. Market Revenue and Volume Forecast, by Application
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Source
11.1.4.2. Market Revenue and Volume Forecast, by Form
11.1.4.3. Market Revenue and Volume Forecast, by Application
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Source
11.1.5.2. Market Revenue and Volume Forecast, by Form
11.1.5.3. Market Revenue and Volume Forecast, by Application
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Source
11.2.2. Market Revenue and Volume Forecast, by Form
11.2.3. Market Revenue and Volume Forecast, by Application
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Source
11.2.4.2. Market Revenue and Volume Forecast, by Form
11.2.4.3. Market Revenue and Volume Forecast, by Application
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Source
11.2.5.2. Market Revenue and Volume Forecast, by Form
11.2.5.3. Market Revenue and Volume Forecast, by Application
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Source
11.2.6.2. Market Revenue and Volume Forecast, by Form
11.2.6.3. Market Revenue and Volume Forecast, by Application
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Source
11.2.7.2. Market Revenue and Volume Forecast, by Form
11.2.7.3. Market Revenue and Volume Forecast, by Application
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Source
11.3.2. Market Revenue and Volume Forecast, by Form
11.3.3. Market Revenue and Volume Forecast, by Application
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Source
11.3.4.2. Market Revenue and Volume Forecast, by Form
11.3.4.3. Market Revenue and Volume Forecast, by Application
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Source
11.3.5.2. Market Revenue and Volume Forecast, by Form
11.3.5.3. Market Revenue and Volume Forecast, by Application
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Source
11.3.6.2. Market Revenue and Volume Forecast, by Form
11.3.6.3. Market Revenue and Volume Forecast, by Application
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Source
11.3.7.2. Market Revenue and Volume Forecast, by Form
11.3.7.3. Market Revenue and Volume Forecast, by Application
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Source
11.4.2. Market Revenue and Volume Forecast, by Form
11.4.3. Market Revenue and Volume Forecast, by Application
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Source
11.4.4.2. Market Revenue and Volume Forecast, by Form
11.4.4.3. Market Revenue and Volume Forecast, by Application
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Source
11.4.5.2. Market Revenue and Volume Forecast, by Form
11.4.5.3. Market Revenue and Volume Forecast, by Application
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Source
11.4.6.2. Market Revenue and Volume Forecast, by Form
11.4.6.3. Market Revenue and Volume Forecast, by Application
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Source
11.4.7.2. Market Revenue and Volume Forecast, by Form
11.4.7.3. Market Revenue and Volume Forecast, by Application
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Source
11.5.2. Market Revenue and Volume Forecast, by Form
11.5.3. Market Revenue and Volume Forecast, by Application
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Source
11.5.4.2. Market Revenue and Volume Forecast, by Form
11.5.4.3. Market Revenue and Volume Forecast, by Application
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Source
11.5.5.2. Market Revenue and Volume Forecast, by Form
11.5.5.3. Market Revenue and Volume Forecast, by Application
12.1. NutraScience Labs
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BASF SE
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Western Drugs Ltd.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Fengchen Group Co., Ltd
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Spectrum Chemical Mfg. Corp
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Vertellus Specialties, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Graham Chemical
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. DSM
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Glanbia plc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Jubilant Life Sciences Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample